Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
Healthtrust
Deloitte
Boehringer Ingelheim
Moodys
Farmers Insurance
Chinese Patent Office
UBS
Medtronic

Generated: January 23, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN ESTOLATE Drug Profile

« Back to Dashboard

Drug patent expirations by year for ERYTHROMYCIN ESTOLATE
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN ESTOLATE

US Patents and Regulatory Information for ERYTHROMYCIN ESTOLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062162-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs Inc ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062169-001 Oct 17, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062087-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs Inc ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062169-002 Oct 17, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062162-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062237-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062409-001 Dec 16, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062353-001 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Life Labs ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062362-001 Dec 17, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Johnson and Johnson
Accenture
US Army
Argus Health
Baxter
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot